Oncology Videos
-
The value of MRD assessment in oligometastic colorectal cancer
John Strickler, MD; Tanios S. Bekaii-Saab, MD
-
Updates from ASCO 2026: Does MRD testing present a molecular window of opportunity for pancreatic cancer?
John Strickler, MD; Ryne Ramaker, MD, PhD
-
Integrating NORTHSTAR/COMPEL Into Clinical Practice: A Tumor Board Focused on Duration of Osimertinib Therapy
Zofia Piotrowska, MD, MHS; Charu Aggarwal, MD, MPH
-
Colorectal cancer updates from ASCO 2026: Impact of ctDNA and MRD testing on guiding adjuvant chemotherapy and treatment response monitoring
John Strickler, MD; Tanios S. Bekaii-Saab, MD
-
Post ASCO Update on Management of HER2+ Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
Tanios S. Bekaii-Saab, MD
